QA: Arcutis Biotherapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001787306_2024_Arcutis_Biotherapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001787306, Arcutis Biotherapeutics Inc

  xvar xval
0 AssetsCurrent 330,431,000
1 IntangibleAssetsNetIncludingGoodwill 6,438,000
2 PropertyPlantAndEquipmentNet 1,539,000
3 remainder_Assets 2,957,000
4 LiabilitiesCurrent 46,668,000
5 LiabilitiesNoncurrent 206,030,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 4,987,000
8 SellingGeneralAndAdministrativeExpense 500,152,501
9 ResearchAndDevelopmentExpense 100,265,730
10 remainder_Expenses 193,180,000
11 remainder_Revenues 339,206,000
12 remainder_NetIncome -9,809,746
13 remainder_ComprehensiveNetIncome -827,041
  yvar yval
0 Assets 341,365,000
1 Liabilities 252,698,000
2 Expenses 798,585,231
3 Revenues 339,206,000
4 StockholdersEquity 88,667,000
5 NetIncome -469,188,977
6 ComprehensiveNetIncome -469,602,498
7 BaseVar 871,245,509
8 EconomicCapitalRatiobeforeLimitedLiability -0.930
9 EconomicCapitalRatio 1.32

Edgar->Model Mapping

Feature Distribution

Change over Time